Cold Water Technologies has developed a new way to help pets with dermatitis. This great tasting add-on to pet food is a new way to decrease incidence of hot spots and itching.

Commercialized a breakthrough poultry health feed ingredient (Cosabody™) developed as a Postdoctoral Student at University of Wisconsin:Improved the technology for quantification of antibody titer levels in commercial egg yolk and poultry feedDesigned a robust peptide sequence for the manufacturing of the stimulant/vaccineProduced stimulant/vaccine to enable commercial-scale immunization of laying hens for the production of Cosabody™Collaborated with Process Engineering and Manufacturing to design and build large scale manufacturing capability of Cosabody™Led efforts developing drying and encapsulation processes to allow for survival of the antibody during pelletization of poultry feedCollaborated with the largest global Animal Health Company on the launch of Cosabody™ as a feed supplement for gut health and coccidiosis preventionEnsured that challenge studies at University of Wisconsin and poultry integrators comply with all Institutional Animal Care and Use Committtee and United Egg Producer guidelines for humane handling of hens and animal welfare protocolsDeveloped a proprietary commercial mucosa-based feed ingredient to improve feed efficiency and weight gain in poultry, and dermatitis control in dogs. The rights of this product were sold to a major pork producer worldwideCreated a strategic plan for go-to-market for customers of feed ingredients Designed and executed necessary challenge studies to determine the validity of the product performance and claimsDeveloped pasteurization processes to ensure antibody survival and food safety regulations (FSMA) in egg yolks and mucosaPartnered with key customers to develop an innovation pipeline for poultry animal nutrition and health. Many of these had application to other animal speciesDesigned and led feed trials at poultry integrators, producers, and laying hen farms to demonstrate product efficacy and ease of implementation

Co-developed an antibody to interleukin-10 (Cosabody™) to improve disease resistance and overall gut health in poultry Designed a peptide sequence for stimulant/vaccine manufacturing that induces laying hens to transfer IL-10 antibody to egg yolksDesigned and executed research challenge studies to demonstrate the efficacy of IL-10 antibodies in improving gut health and disease prevention in commercial poultry flocksListed as patent holder of antibody-based feed ingredients Cosabody™ and Cosatein™

I studied the role of PKCepsilon in UVR induced skin carcinogenesis.

I am a key member of a team with experience in microbiology and PCR.

I worked for the Center for Nanoscale Science and Engineering.